PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1378568
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1378568
Global small molecule prefilled syringes market is estimated to be valued at US$ 18.98 Bn in 2023, and is expected to exhibit a CAGR of 5.2% during the forecast period (2023-2030).
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2022 | Market Size in 2023: | US$ 18.98 Bn |
Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
Forecast Period 2023 to 2030 CAGR: | 5.20% | 2030 Value Projection: | US$ 27.06 Bn |
A disposable needle-based injection system with a pre-filled syringe that has a specific medication already inside is known as prefilled syringe (PFS). A prefilled glass syringe is frequently used in auto-injectors to hold and administer drugs. In order to ensure the integrity and functionality of the syringe system, proper containment and drug expulsion, and the highest level of patient comfort, various components of the prefilled syringes must be tested using a variety of standard tests. There are different types of prefilled syringes (PFS) that includes glass or plastic, with or without needle. Glass prefilled syringe represents the most experience in the industry and continues to supply the majority of prefilled syringe packaging. The PFS has a multi-component complexity along with, in certain cases, life-saving benefits. It consists of a barrel, a needle, a needle shield, a plunger, and a closure, all of which must work in unison and safely with the pre-filled medicine. In order to maintain a sterile barrier against potential contaminants, the container closure integrity (CCI), which refers tothe appropriateness of the syringe closure mechanismis also crucial. So,all PFS versions are tightly governed by international standards and put to testing.
Increasing product approvals by government regulatory authority in the market is expected to drive growth of the global small molecule prefilled syringes market over the forecast period. For instance, in January 2022, Owen Mumford Pharmaceutical Services, division of Owen Mumford Ltd., a medical device manufacturer, announced that its UniSafe 1mL safety device for pre-filled syringes had been approved as a combination product in Asia Pacific. UniSafe 1ml had also received regulatory approval in Europe and is also available in the market as a combination product with a drug to treat rheumatoid arthritis. UniSafe 1ml is a prefilled syringe safety device that offers numerous benefits to both pharmaceutical companies and their patients due to its unique, spring-free, patented design.
Global Small Molecule Prefilled Syringes Market Detailed Segmentation: